Description of the drug
The drug Ibrance / Reampla (palbociclib) 125 mg is manufactured by Pfizer and is used for the chemotherapy of solid tumors. This drug has trade names Ibrance and Reampla, active ingredient - palbociclib, dosage 125 mg. Each pack contains 21 tablets.
Indications for use
The drug is intended for the treatment of cases of solid tumors. It helps to fight oncological diseases.
Advantages
- High quality manufacturer - Pfizer
- Convenient dosage form in the form of tablets
Effectiveness
Application
The drug should be taken as recommended by a doctor. It is usually prescribed for long-term treatment.
Who is suitable
The drug is suitable for adult patients who need chemotherapy to fight cancerous diseases.
Search queries
This drug is also searched for as: chemotherapy of solid tumors, palbociclib 125 mg, tablets for cancer.
Characteristics
Chemical name
Палбоцикліб
Commercial name
Ібранс, Реампла
Dosage
125 мг
Manufacturer
Pfizer
Number
21
Release form
Пігулки